These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26558298)

  • 1. Emerging drugs for common conditions of sleepiness: obstructive sleep apnea and narcolepsy.
    Sullivan SS; Guilleminault C
    Expert Opin Emerg Drugs; 2015; 20(4):571-82. PubMed ID: 26558298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstructive sleep apnea in narcolepsy.
    Sansa G; Iranzo A; Santamaria J
    Sleep Med; 2010 Jan; 11(1):93-5. PubMed ID: 19699146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy.
    Rosenberg R; Thorpy MJ; Dauvilliers Y; Schweitzer PK; Zammit G; Gotfried M; Bujanover S; Scheckner B; Malhotra A
    J Clin Sleep Med; 2022 Jan; 18(1):235-244. PubMed ID: 34283019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: A meta-analysis from randomized controlled trials.
    Wang J; Li X; Yang S; Wang T; Xu Z; Xu J; Gao H; Chen G
    Pharmacol Res; 2021 May; 167():105522. PubMed ID: 33667687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of home sleep testing for evaluation of patients with excessive daytime sleepiness: focus on obstructive sleep apnea and narcolepsy.
    Rosenberg R; Hirshkowitz M; Rapoport DM; Kryger M
    Sleep Med; 2019 Apr; 56():80-89. PubMed ID: 30803831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal treatment of obstructive sleep apnea and excessive sleepiness.
    Rosenberg R; Doghramji P
    Adv Ther; 2009 Mar; 26(3):295-312. PubMed ID: 19337706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational therapies for the treatment of narcolepsy.
    de Biase S; Nilo A; Gigli GL; Valente M
    Expert Opin Investig Drugs; 2017 Aug; 26(8):953-963. PubMed ID: 28726523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure.
    Gasa M; Tamisier R; Launois SH; Sapene M; Martin F; Stach B; Grillet Y; Levy P; Pepin JL;
    J Sleep Res; 2013 Aug; 22(4):389-97. PubMed ID: 23409736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitolisant for treating patients with narcolepsy.
    Li S; Yang J
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):79-84. PubMed ID: 31937172
    [No Abstract]   [Full Text] [Related]  

  • 11. Narcolepsy in adolescents.
    Sullivan SS
    Adolesc Med State Art Rev; 2010 Dec; 21(3):542-55, x-xi. PubMed ID: 21302860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.
    Weaver TE; Pepin JL; Schwab R; Shapiro C; Hedner J; Ahmed M; Foldvary-Schaefer N; Strollo PJ; Mayer G; Sarmiento K; Baladi M; Bron M; Chandler P; Lee L; Malhotra A
    J Clin Sleep Med; 2021 Oct; 17(10):1995-2007. PubMed ID: 34606437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives.
    Abad VC
    Nat Sci Sleep; 2021; 13():75-91. PubMed ID: 33531850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On treatment but still sleepy: cause and management of residual sleepiness in obstructive sleep apnea.
    Launois SH; Tamisier R; Lévy P; Pépin JL
    Curr Opin Pulm Med; 2013 Nov; 19(6):601-8. PubMed ID: 24060983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the treatment and management of excessive daytime sleepiness.
    Black J; Duntley SP; Bogan RK; O'Malley MB
    CNS Spectr; 2007 Feb; 12(2 Suppl 2):1-14; quiz 15. PubMed ID: 17277717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea.
    Abad VC; Guilleminault C
    Expert Rev Respir Med; 2018 Dec; 12(12):1007-1019. PubMed ID: 30365900
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow-up of patients with narcolepsy-cataplexy treated with sodium oxybate (Xyrem).
    Alshaikh MK; Gacuan D; George S; Sharif M; Bahammam AS
    Clin Neuropharmacol; 2011; 34(1):1-4. PubMed ID: 21206362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daytime variation in performance and tiredness/sleepiness ratings in patients with insomnia, narcolepsy, sleep apnea and normal controls.
    Schneider C; Fulda S; Schulz H
    J Sleep Res; 2004 Dec; 13(4):373-83. PubMed ID: 15560772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.
    Krystal AD; Benca RM; Rosenberg R; Schweitzer PK; Malhotra A; Babson K; Lee L; Bujanover S; Strohl KP
    J Psychiatr Res; 2022 Nov; 155():202-210. PubMed ID: 36070638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea.
    Malhotra A; Shapiro C; Pepin JL; Hedner J; Ahmed M; Foldvary-Schaefer N; Strollo PJ; Mayer G; Sarmiento K; Baladi M; Chandler P; Lee L; Schwab R
    Sleep; 2020 Feb; 43(2):. PubMed ID: 31691827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.